CIK 0001020214
- Accelerated filer
CERUS CORP
Sign in to watch- Ticker
- CERS
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680262011
- Phone
- +1 925-288-6000
- Business address
- 1220 CONCORD AVENUE, SUITE 600, CONCORD, CA, 94520
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2010-09-01 | CORASH LAURENCE M Chief Medical Officer | Grant or award · Option (Right to Buy) | +75,000 | 75,000 | ||
| 2010-09-01 | Hogeboom Caspar Jan Managing Director Cerus Europe | Grant or award · Option (Right to Buy) | +75,000 | 75,000 | ||
| 2010-09-01 | GLASSELL CLAES Executive Officer and Director | Grant or award · Option (Right to Buy) | +200,000 | 200,000 | ||
| 2010-09-01 | Green Kevin Dennis Chief Accounting Officer | Grant or award · Option (Right to Buy) | +50,000 | 50,000 | ||
| 2010-09-01 | ERVIN HOWARD G Vice President, Legal Affairs | Grant or award · Option (Right to Buy) | +45,000 | 45,000 | ||
| 2010-03-05 | CORASH LAURENCE M Chief Medical Officer | Grant or award | +10,598 | $2.06 | $22K | 323,814 |
Page 66 of 66 · 1,306 trades